Freenome, Inc. Common stock (FRNM) News

Latest headlines that mention FRNM, newest first · each headline opens the original publisher

FRNM quote

Last price: $12.92
Day change: -7.78%
Next earnings: 2026-11-10 AMC

Quote & chart Expected move Insider trading IV rank history

FRNM headlines

latest coverage

Not much coverage yet. FRNM has appeared in only a few headlines lately; new stories show up here as publishers cover it.

Investing.com 5d ago

Cathie Wood’s ARK sells Personalised stock, buys Freenome shares

General T3FRNM

Seeking Alpha News 1mo ago

Freenome: SimpleScreen CRC Unlocks A 50M Patient TAM, Bypassing Competition

General T2FRNM

Seeking Alpha 2mo ago

Freenome GAAP EPS of -$2.59

Earnings T2FRNM

Investing.com 2mo ago

Freenome receives FDA breakthrough designation for lung cancer test

General T3FRNM

Investing.com 3mo ago

Freenome to begin trading on Nasdaq following SPAC merger

M&A T3FRNM

IBD 3mo ago

The Surprising Reason Guardant Health, A Top 3% Stock, Soared To A Five-Year High

Guardant Health stock jumped Thursday after key competitor, Freenome, unveiled study results for its colon cancer blood test. The post The Surprising Reason Guardant Health, A Top 3% Stock, Soared To A Five-Year High appeared first on Investor's Business Daily .

General T2FRNM GH

FRNM news alerts

Get an alert by email or push when a new headline mentions FRNM.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.